Treatment of orbital non-hodgkin's lymphomas

Role of radiotherapy

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Non-Hodgkin's lymphomas constitute the most common malignancy of the orbit. Characteristics and treatment modality are not well defined due to the rarity of this tumor. Between 1988 and 1990, five patients with orbital lymphomas were treated in the authors' department. There were three females and two males ranging in age from 55 to 83 years. Three patients were stage I E, one patient was stage IV E and one was stage II E. Two patients received chemotherapy and radiation therapy. Radiation alone was administered to three patients. Median radiation dose was 3500 cGy. Late effects of radiotherapy have not been recorded up to the present. Local control was 100% but three patients had systemic progression disease. Up to date all the patients are alive.

Original languageEnglish
Pages (from-to)189-191
Number of pages3
JournalOrbit
Volume11
Issue number4
DOIs
Publication statusPublished - 1992

Fingerprint

Non-Hodgkin's Lymphoma
Radiotherapy
Therapeutics
Radiation
Orbit
Disease Progression
Neoplasms
Drug Therapy

Keywords

  • Non-Hodgkin's lymphomas
  • Orbital
  • Radiotherapy

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Treatment of orbital non-hodgkin's lymphomas : Role of radiotherapy. / Bacigalupo, Almalina; Barra, Salvina; Scolaro, Tindaro; Corvo, Renzo; Guenzi, Marina; Vitale, Vito.

In: Orbit, Vol. 11, No. 4, 1992, p. 189-191.

Research output: Contribution to journalArticle

@article{a5f226193c394d63bd2d41fbe3e379bb,
title = "Treatment of orbital non-hodgkin's lymphomas: Role of radiotherapy",
abstract = "Non-Hodgkin's lymphomas constitute the most common malignancy of the orbit. Characteristics and treatment modality are not well defined due to the rarity of this tumor. Between 1988 and 1990, five patients with orbital lymphomas were treated in the authors' department. There were three females and two males ranging in age from 55 to 83 years. Three patients were stage I E, one patient was stage IV E and one was stage II E. Two patients received chemotherapy and radiation therapy. Radiation alone was administered to three patients. Median radiation dose was 3500 cGy. Late effects of radiotherapy have not been recorded up to the present. Local control was 100{\%} but three patients had systemic progression disease. Up to date all the patients are alive.",
keywords = "Non-Hodgkin's lymphomas, Orbital, Radiotherapy",
author = "Almalina Bacigalupo and Salvina Barra and Tindaro Scolaro and Renzo Corvo and Marina Guenzi and Vito Vitale",
year = "1992",
doi = "10.3109/01676839209010267",
language = "English",
volume = "11",
pages = "189--191",
journal = "Orbit",
issn = "0167-6830",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Treatment of orbital non-hodgkin's lymphomas

T2 - Role of radiotherapy

AU - Bacigalupo, Almalina

AU - Barra, Salvina

AU - Scolaro, Tindaro

AU - Corvo, Renzo

AU - Guenzi, Marina

AU - Vitale, Vito

PY - 1992

Y1 - 1992

N2 - Non-Hodgkin's lymphomas constitute the most common malignancy of the orbit. Characteristics and treatment modality are not well defined due to the rarity of this tumor. Between 1988 and 1990, five patients with orbital lymphomas were treated in the authors' department. There were three females and two males ranging in age from 55 to 83 years. Three patients were stage I E, one patient was stage IV E and one was stage II E. Two patients received chemotherapy and radiation therapy. Radiation alone was administered to three patients. Median radiation dose was 3500 cGy. Late effects of radiotherapy have not been recorded up to the present. Local control was 100% but three patients had systemic progression disease. Up to date all the patients are alive.

AB - Non-Hodgkin's lymphomas constitute the most common malignancy of the orbit. Characteristics and treatment modality are not well defined due to the rarity of this tumor. Between 1988 and 1990, five patients with orbital lymphomas were treated in the authors' department. There were three females and two males ranging in age from 55 to 83 years. Three patients were stage I E, one patient was stage IV E and one was stage II E. Two patients received chemotherapy and radiation therapy. Radiation alone was administered to three patients. Median radiation dose was 3500 cGy. Late effects of radiotherapy have not been recorded up to the present. Local control was 100% but three patients had systemic progression disease. Up to date all the patients are alive.

KW - Non-Hodgkin's lymphomas

KW - Orbital

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=0027062901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027062901&partnerID=8YFLogxK

U2 - 10.3109/01676839209010267

DO - 10.3109/01676839209010267

M3 - Article

VL - 11

SP - 189

EP - 191

JO - Orbit

JF - Orbit

SN - 0167-6830

IS - 4

ER -